Mulya.ai
Ticker
HCA
Scenario
Key Inputs
Revenue est.?Analyst
OP margin est.?Analyst
Reinvestment est.?projected
R&D capitalizedNo
Leases factoredNo
Key Assumptions
WACC ?9.2%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?1.134
Beta (levered) ?1.634
Terminal OM% ?17.5%
Segment conc. ?51% dominant
Terminal growth ?4.1%
Bond rating ?A · 1.20%
ROIC option ?Opt 4 · 23.6%
Prob of failure ?0.0%
Pipeline validated · 2026-07-21

HCA · HCA Healthcare, Inc.

$391.682026-07-21
Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Facilities

Intrinsic Value Range Comparison · Mulya.ai

Bull
$1076
+174.7% vs market
Base · active
$762
+94.5% vs market
Bear
$679
+73.3% vs market
Mulya.ai vs Analyst IV Comparison?
Market $392
Median $520
Bear $679
Base $762
Bull $1076
Market Price $392
Mulya.ai Base $762
Analysts Median $520
Mulya.ai IV range ($679 · $1076)
Analysts Range ($413 · $635)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2024.Q1$65.0B14.8%20.9%$7.6B−$1.8B$5.8B9.1%20.4%$37.3B$23.13
2024.Q4$65.0B0.0%14.8%21.9%$7.5B−$1.9B$5.6B9.9%19.7%$38.9B$23.13
2025.Q1$70.6B8.7%14.9%22.4%$8.2B−$2.9B$5.3B9.6%20.7%$40.0B$25.41
2025.Q4$70.6B0.0%14.9%20.9%$8.3B$493MM$8.8B10.0%20.5%$41.3B$25.41
2026.Q1$76.4B8.2%15.7%20.2%$9.6B$988MM$10.5B9.4%23.3%$40.8B$29.987.4
italics below = DCF projection · 10yr Rev CAGR: 5.3%
2027.Q1$79.5B+4.0%15.8%20.2%$10.0B−$1.6B$8.4B9.2%$7.7B24.1%$42.4B$44.228.9
2028.Q1$83.4B+4.9%15.8%20.2%$10.5B−$2.0B$8.5B9.1%$7.1B24.3%$44.4B$46.418.4
2029.Q1$88.0B+5.5%15.8%20.1%$11.1B−$2.4B$8.7B9.1%$6.7B24.4%$46.8B$48.988.0
2030.Q1$93.3B+6.0%15.8%20.1%$11.8B$0MM$11.8B9.0%$8.3B25.2%$46.8B$51.957.5
2031.Q1$99.6B+6.8%15.8%20.1%$12.6B$0MM$12.6B8.9%$8.1B26.9%$46.8B$55.497.1
Term. Yr+$133.5B4.1%17.5%20.0%$18.7B−$3.2B$15.4B8.6%$146.0B23.6%
Active scenario IV: $762 (+94.5% vs market)